Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial

DiscussionThe trial results may provide information on new therapeutic options as multi-target neuroprotection might mitigate reperfusion injury in patients with acute ischemic stroke before EVT.Trial registrationClinicalTrials.gov, ID:NCT02831088. Registered on 13 July 2016.

http://link.springer.com/10.1186/s13063-018-2746-9

Source: Trials - July 13, 2018 Category: Research Source Type: clinical trials